You are here: Industry Insights > CROs

News List

Pharmaceutical Drug Policies: A Comparative Analysis Across Nations Saher Haider
July 02, 2024
Pharmaceutical products are the heart of the healthcare system, yet their accessibility remains a challenge for people across the globe.
New Research Launched at BIO24 Finds CROs with In-house Regulatory Affairs Can Deliver 30% Savings, Halve Timelines and Cut Risks for Biotechs PharmaSources
June 05, 2024
New research showes that biotechs can save more than 30% in costs, halve start-up times, and cut risk with CROs that have in-house scientific and regulatory affairs.
Clinical Research Organization's (CROs) using Artificial Intelligence (AI) tools in restructuring the clinical trials Shruti Talashi
April 11, 2024
Healthcare is embracing AI for better diagnosis, drug development, and patient care.
Vetter Earns Prestigious Honors Across All Core Categories in the 13th Annual CDMO Leadership Awards PharmaSources
March 27, 2024
Vetter once again earned the 2024 CDMO Leadership Awards in all six core categories – quality, expertise, reliability, capabilities, compatibility and service for big pharma, small pharma and overall respondents.
Updates for the Janssen and AstraZeneca Vaccines Cross-contamination Lin Zhang
July 13, 2021
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) that causes COVID-19 pandemic has spread to over 220 countries and territories around the world as of July 2021.
Vaccine Rollout Across the World, Does it Fix the Problem? Sarah Harding
June 29, 2021
I am getting my second COVID vaccination on Friday. If you are reading this from China or the UK, you’re probably thinking, “Oh, I already have both my jabs.”
Advantages to Using CROs Lin Zhang
November 12, 2020
Today, contract research organizations (CROs) provide crucial services for almost any point along the drug pipeline.
Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services PRNewswire
December 12, 2024
Manulife Hong Kong today announced a new partnership with New Frontier Group, one of the leading healthcare service providers in Greater China, to introduce cashless services for eligible customers through New Frontier Group's subsidiary, Prosper Health.
Sirtex Medical and Grand Pharmaceutical Group Limited receive NDA approval of SIR-Spheres® Y-90 resin microspheres in China from the National Medical Products Administration prnasia
February 11, 2022
Sirtex Medical ("Sirtex"), a leading manufacturer of targeted liver cancer therapies, announced today with its shareholder, Grand Pharmaceutical Group Limited, that SIR-Spheres® Y-90 resin microspheres...
While Omicron continues to dominate across the world, COVID-19 travel requirements remain pharmatimes
January 15, 2022
The scandal surrounding Novak Djokovic’s entry into Australia, following his vaccine exemption, has sparked outcry on both a national and global scale.